Table 3 Vascular complications, surgery, COVID 19 and mortality in relation to pathology findings
Variables | Pathology | Total (n = 24) | X2 | P value | ||
|---|---|---|---|---|---|---|
Mucormycosis (n = 13) | Aspergillosis (n = 11) | |||||
Vascular complications no (%) | ||||||
ICA attenuation | 4 (33.33%) | 0 (0.00%) | 4 (16.67%) | 4.062 | 0.044* | |
ICA thrombosis | 8 (61.54%) | 7 (63.64%) | 15 (62.50%) | 0.011 | 0.916 | |
ICA pseudo aneurysm | 1 (7.69%) | 1 (1.09%) | 2 (8.33%) | 0.015 | 0.902 | |
Cavernous sinus thrombosis | 7 (53.85%) | 9 (81.82%) | 16 (66.67%) | 2.098 | 0.148 | |
Ophthalmic vein thrombosis | 4 (33.33%) | 5 (45.45%) | 9 (37.50%) | 0.548 | 0.459 | |
Surgery type, no (%) | ||||||
Endoscopic | 3 (23.08%) | 4 (36.36%) | 7 (29.17%) | 0.513 | 0.774 | |
Surgical debridement | 7 (53.85%) | 5 (45.45%) | 12 (50.00%) | |||
Combined | 3 (23.08%) | 2 (18.18%) | 5 (20.83%) | |||
COVID-19, no (%) | ||||||
Negative | 5 (38.46%) | 6 (54.55%) | 11 (45.83%) | 0.621 | 0.431 | |
Positive | 8 (61.54%) | 5 (45.45%) | 13 (54.17%) | |||
Mortality, no (%) | ||||||
Yes | 5 (38.46%) | 5 (45.45%) | 10 (41.67%) | 0.120 | 0.729 | |
No | 8 (61.54%) | 6 (54.55%) | 14 (58.33%) | |||